Pakistan Tehreek-e-Insaf (PTI) founder Imran Khan was admitted to the Pakistan Institute of Medical Sciences (PIMS) on Monday for a scheduled follow-up eye treatment. During his visit, doctors administered his fifth intravitreal injection after medical evaluations indicated progress in his condition.
The 74-year-old politician, currently held at Rawalpindi’s Adiala jail, is undergoing ongoing treatment for a serious eye disorder that requires multiple intravitreal injections. Ophthalmologists at PIMS conducted a thorough examination before the procedure and confirmed that he was clinically stable.
His optical coherence tomography (OCT) scan revealed signs of clinical improvement, hospital officials. The injection was performed under microscopic guidance by specialist surgeons and completed as a day-care procedure without any complications.
Throughout his stay, Imran Khan remained vitally stable before, during, and after the intervention. He was discharged with detailed instructions for further care and follow-up appointments.
This latest injection marks the fifth dose in his ongoing ophthalmic treatment regimen. Previously, he was transferred from Adiala jail to PIMS on April 28, when he received the fourth injection following a comprehensive eye examination.
While the hospital has not disclosed the exact diagnosis or medication used, intravitreal injections are commonly applied to treat retinal diseases such as diabetic retinopathy, retinal vein occlusion, and age-related macular degeneration.
Officials have not specified the timing of the next follow-up, but patients undergoing serial intravitreal injections are typically monitored regularly to evaluate treatment response and determine the necessity of further doses.
In a significant development, the jailed PTI leader was diagnosed with central retinal vein occlusion (CRVO), a severe eye condition, as detailed in a report submitted to the Supreme Court by his lawyer and the court’s amicus curiae, Salman Safdar. CRVO occurs when the main vein responsible for draining blood from the retina becomes blocked. This condition is often linked to cardiovascular risk factors such as hypertension, high cholesterol, diabetes, and heart disease.
